Combined Antihistaminics Therapy in COVID 19 Patients
Status:
Not yet recruiting
Trial end date:
2022-01-13
Target enrollment:
Participant gender:
Summary
The use of antihistaminic medications could result in a significant immune modulation which
may help in the treatment of cytokine storm of COVID-19.Thus, the aim of this study is to
evaluate efficacy and safety of famotidine and loratadine combination in covid 19 treatment
protocol.